Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Lymphoma, B-Cell, Marginal Zone

imatinib mesylate has been researched along with Lymphoma, B-Cell, Marginal Zone in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hammerl, P; Krisch, LM; Posselt, G; Wessler, S1
Hyatt, BJ; Paull, PE; Wassef, W1
Cogliatti, SB; Craig, VJ; Müller, A; Rehrauer, H; Wündisch, T1
Blay, JY; Bompas, E; Velay, B1

Reviews

1 review(s) available for imatinib mesylate and Lymphoma, B-Cell, Marginal Zone

ArticleYear
Gastric oncology: an update.
    Current opinion in gastroenterology, 2009, Volume: 25, Issue:6

    Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Benzamides; Endoscopy, Gastrointestinal; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Lymphoma, B-Cell, Marginal Zone; Neoplasm Metastasis; Neoplasm Staging; Piperazines; Pyrimidines; Stomach Neoplasms

2009

Other Studies

3 other study(ies) available for imatinib mesylate and Lymphoma, B-Cell, Marginal Zone

ArticleYear
CagA Phosphorylation in Helicobacter pylori-Infected B Cells Is Mediated by the Nonreceptor Tyrosine Kinases of the Src and Abl Families.
    Infection and immunity, 2016, Volume: 84, Issue:9

    Topics: Antigens, Bacterial; B-Lymphocytes; Bacterial Proteins; Cell Line, Tumor; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Imatinib Mesylate; Lymphoma, B-Cell, Marginal Zone; Phosphorylation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-abl; Signal Transduction; src-Family Kinases; U937 Cells

2016
Epigenetic silencing of microRNA-203 dysregulates ABL1 expression and drives Helicobacter-associated gastric lymphomagenesis.
    Cancer research, 2011, May-15, Volume: 71, Issue:10

    Topics: Animals; Benzamides; Biopsy; Cell Line, Tumor; Disease Progression; Epigenesis, Genetic; Female; Gene Silencing; Helicobacter pylori; Humans; Imatinib Mesylate; Lymphoma, B-Cell, Marginal Zone; Mice; Mice, Inbred BALB C; MicroRNAs; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Oncogene Proteins v-abl; Piperazines; Pyrimidines; Stomach Neoplasms

2011
Combination treatment of rituximab and imatinib mesylate for simultaneous relapse of MALT lymphoma and a gastrointestinal stromal tumor.
    Leukemia & lymphoma, 2004, Volume: 45, Issue:11

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Piperazines; Prednisolone; Pyrimidines; Recurrence; Rituximab; Vincristine

2004